Nebula Research & Development’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Nebula Research & Development’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,446	Closed	-$381K	–	1168
2024 Q3	$381K	Buy	+11,446	New	+$394K	0.05%	637

Nebula Research & Development's LBPH Position: Q4 2024 in Review

Nebula Research & Development sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 11,446 shares — an estimated $381K sold.

Nebula Research & Development first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $381K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Nebula Research & Development reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Nebula Research & Development sold 11,446 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $381K.
Nebula Research & Development first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Nebula Research & Development's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $381K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Nebula Research & Development's 13F filing for Q4 2024, filed 14 Feb 2025.